Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
4.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
4
years
Avg Time Held Equity only
4.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
AMN Healthcare
AMN
$1.46B
| $452K | ﹤0.01% |
24,672
+7,439
| +43% | +$141K |
2024 Q4
5 quarters
|
|
3102
iShares US Tech Independence Focused ETF
IETC
$699M
| $452K | ﹤0.01% |
5,114
-450
| -8% | -$42.6K |
2020 Q3
22 quarters
|
|
3103
ARK Next Generation Technology ETF
ARKW
$2.22B
| $452K | ﹤0.01% |
3,747
+1,040
| +38% | +$138K |
2024 Q4
5 quarters
|
|
3104
Agios Pharmaceuticals
AGIO
$1.85B
| $451K | ﹤0.01% |
13,333
+2,963
| +29% | +$84K |
2024 Q1
8 quarters
|
|
3105
AudioEye
AEYE
$85.2M
| $451K | ﹤0.01% |
70,732
+577
| +0.8% | +$4.38K |
2020 Q4
21 quarters
|
|
3106
Certara
CERT
$1.43B
| $450K | ﹤0.01% |
78,917
+68,270
| +641% | +$521K |
2025 Q3
2 quarters
|
|
3107
NeoGenomics
NEO
$2.17B
| $450K | ﹤0.01% |
60,598
+6,632
| +12% | +$69.8K |
2020 Q3
22 quarters
|
|
3108
Dakota Gold
DC
$703M
| $450K | ﹤0.01% |
89,022
+48,062
| +117% | +$284K |
2025 Q3
2 quarters
|
|
3109
Franklin FTSE Japan ETF
FLJP
$4.21B
| $448K | ﹤0.01% |
12,387
-171
| -1% | -$6.33K |
2025 Q1
4 quarters
|
|
3110
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$861M
| $448K | ﹤0.01% |
+17,194
| New | +$453K |
2026 Q1
0 quarters
|
|
3111
Harley-Davidson
HOG
$2.81B
| $447K | ﹤0.01% |
22,119
+11,079
| +100% | +$217K |
2013 Q2
51 quarters
|
|
3112
Northwest Bancshares
NWBI
$2.15B
| $447K | ﹤0.01% |
35,203
-10,045
| -22% | -$126K |
2020 Q2
23 quarters
|
|
3113
JPMorgan Active Growth ETF
JGRO
$9.96B
| $447K | ﹤0.01% |
5,285
-283
| -5% | -$25.2K |
2024 Q4
5 quarters
|
|
3114
Inhibrx
INBX
$1.25B
| $445K | ﹤0.01% |
6,618
+910
| +16% | +$67.5K |
2025 Q4
1 quarter
|
|
3115
Fifth District Bancorp
FDSB
$88.2M
| $445K | ﹤0.01% |
30,000
-10,000
| -25% | -$149K |
2024 Q3
6 quarters
|
|
3116
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.23B
| $444K | ﹤0.01% |
384
+9
| +2% | +$11K |
2021 Q4
17 quarters
|
|
3117
Embecta
EMBC
$350M
| $443K | ﹤0.01% |
50,147
+3,787
| +8% | +$39.5K |
2024 Q2
7 quarters
|
|
3118
CEVA Inc
CEVA
$823M
| $443K | ﹤0.01% |
23,731
+12,284
| +107% | +$258K |
2024 Q3
6 quarters
|
|
3119
BioAge Labs
BIOA
$249M
| $443K | ﹤0.01% |
+25,321
| New | +$488K |
2026 Q1
0 quarters
|
|
3120
BigBear.ai
BBAI
$1.05B
| $443K | ﹤0.01% |
125,812
+35,527
| +39% | +$165K |
2024 Q1
8 quarters
|
|
3121
Red Violet
RDVT
$1.22B
| $442K | ﹤0.01% |
12,787
+1,073
| +9% | +$47.2K |
2025 Q2
3 quarters
|
|
3122
STAAR Surgical
STAA
$1.1B
| $441K | ﹤0.01% |
23,565
+4,592
| +24% | +$87.7K |
2024 Q2
7 quarters
|
|
3123
Dimensional World Equity ETF
DFAW
$1.68B
| $440K | ﹤0.01% |
5,965
+564
| +10% | +$42.9K |
2025 Q2
3 quarters
|
|
3124
Atlas Energy Solutions
AESI
$1.38B
| $440K | ﹤0.01% |
33,520
-1,266
| -4% | -$14.8K |
2025 Q1
4 quarters
|
|
3125
Cogent Communications
CCOI
$395M
| $439K | ﹤0.01% |
23,296
-1,280
| -5% | -$28.2K |
2015 Q3
42 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.